GoodRx Releases First Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to GoodRx Releases First Quarter 2022 Financial Results

GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 2c, Guidance Misses

May 9, 2022 4:19 PM EDT

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.10, $0.02 better than the analyst estimate of $0.08. Revenue for the quarter came in at $203.3 million versus the consensus estimate of $200.2 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q2 2022 revenue of $190 million, versus the consensus of $215.6 million.

As discussed above in relation to Q1 2022 prescription transactions revenue, we recently recognized a grocery chain had taken actions that impacted acceptance of discounts from most PBMs for a subset of drugs. This impacted the acceptance of many PBM discounts for certain drugs... More